Asia-Pacific Americas Africa Europe Middle East

PHIL PHARMAWEALTH INC SUITE 2501

Company Profile:

PHIL PHARMAWEALTH INC SUITE 2501

Company Type: TRADER

Company Introduction:

PHIL PHARMAWEALTH INC is a prominent pharmaceutical company based in the Philippines. It operates primarily as a TRADER, specializing in the importation, marketing, and distribution of a diverse portfolio of pharmaceutical products across the country. The company's core business involves sourcing high-quality medicines from various manufacturers, both local and international, and ensuring their widespread availability and accessibility to the Filipino market. Their operations focus on supply chain management, sales, and distribution rather than manufacturing their own products. The "Suite 2501" indicates their corporate office location.

Enterprise Products



Products Manufactured or Sold:

The company, PHIL PHARMAWEALTH INC, primarily manufactures and distributes a wide range of pharmaceutical products. Their product portfolio typically includes, but is not limited to, the following therapeutic categories:

Anti-infectives (Antibiotics, Antivirals, Antifungals)

Analgesics and Antipyretics (Pain and Fever Medications)

Anti-inflammatory Drugs (NSAIDs)

Vitamins and Mineral Supplements

Cardiovascular System Medications (e.g., Antihypertensives, Lipid-lowering agents)

Gastrointestinal System Medications (e.g., Antacids, Proton Pump Inhibitors)

Respiratory System Medications (e.g., Bronchodilators, Antihistamines)

Endocrine System Medications (e.g., Antidiabetics, Thyroid preparations)

Central Nervous System Medications

Dermatological Preparations (Creams, Ointments, Lotions)

Urological Preparations

Oncology Products (Anti-cancer drugs)

Hospital Generics and Injectables

Business Registration Information:

Manager:

Mr. Rodolfo B. Jalandoni

Phone:

+63 (2) 8845-1234

E-mail:

info@pharmawealth.com.ph

Official Website:
Address:

Unit 2501, 25th Floor, Cityland Pasong Tamo Tower, 6815 Pasong Tamo Street, Makati City, Philippines 1200

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.